Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions.
52W Range
12thpctl
Volume
0.76×avg
Market Cap
381.62MUSD
P/E Ratio
-4.2TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Lexeo Therapeutics, Inc. Common Stock
LXEONASDAQ Global Market·USD·Closed
Lexeo Therapeutics, Inc. Common Stock
LXEONASDAQ·USD·Closed
$4.86
−2.61%
$4.86
−$0.13 (2.61%)
52W Range
12thpctl
Volume
0.76×avg
Mkt Cap
381.62MUSD
P/E
-4.2TTM
Div Yield
–ann
LXEO: Lexeo Therapeutics, Inc. Common Stock Stock Analysis | finqOS
